Special Programs : Department of Defense Medical Innovation and Biodefense Forum

jun 4, 2018: 9 a.m. - middag
Room 205ABC, Level 2

Opening Keynote Panel: Strategic Vision of the DoD Medical Research, Development, and Acquisition Enterprise
DoD leaders will provide an organizational overview, strategic vision, and priorities for the various intradepartmental agencies that are charged with developing medical solutions for the battlefield with a focus on biomedical research that includes chemical and biological defense, emerging infectious diseases, combat casualty care, and regenerative medicine
Moderator: Phyllis Arthur, Managing Director, Infectious Diseases and Diagnostics Policy, Biotechnology Innovation Organization
Panelists: Dr. Mark Dertzbaugh, Civilian Deputy to the Principal Assistant for Research & Technology, U.S. Army Medical Research and Materiel Command
Dr. Jason Roos, Deputy Program Executive Officer, Joint Program Executive Office for Chemical Biological, Radiological, and Nuclear Defense
Lieutenant Colonel Cindy Landgren, Office of Deputy Assistant Secretary of Defense, Chemical and Biological Defense
Captain Joseph Cohn, Chief, Research Program Administration Division J9, Research & Development Directorate, Defense Health Agency
Dr. David Hone, Chief Scientist, Vaccine and Therapeutic Division, Joint Science and Technology Office, Defense Threat Reduction Agency


Panel 2: Industry Partnerships with the DoD to Drive Medical Innovation
Navigating the expansive DoD medical enterprise can be quite daunting. It is critical to understand how the different acquisition strategies and partnership models can be utilized for various medical technologies. The panelists will explore the variety of mechanisms, many new and innovative, to secure funding and do business with the DoD. This panel will feature both senior DoD officials as well as industry representatives who have a track record of success as DoD partners.
Moderator: Tom Handel, General Manager and President, Meridian Medical Technologies, Inc. (Pfizer)
Panelists: Dr. Clay Holloway, Director of Strategic Initiatives, Joint Project Manager, Medical Countermeasure Systems
Mr. Tim Belski, Joint Product Director, Advanced Development Manufacturing Capabilities, Joint Project Manager, Medical Countermeasure Systems
Dr. J.B. Phillips, Projects Officer, Office of the Principal Assistant for Acquisitions, U.S. Army Medical Research and Materiel Command
Dr. David Hone, Chief Scientist, Vaccine and Therapeutic Division, Joint Science and Technology Office, Defense Threat Reduction Agency
Dr. Mike Stebbins, Consortium Manager, Advanced Technology International
Carmen Maher, Senior Director, Medical Regulatory Affairs, Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense; Defense Threat Reduction Agency, Joint Science and Technology Office
Colonel Nelson Michael, Deputy Commander, Walter Reed Army Institute of Research


Panel 3: Scientific and Technological Approaches to Advance Biodefense and Battlefield Solutions
The mission of the DoD medical enterprise is ensuring our armed forces remain in optimal health and are protected from infectious disease, chemical and biological threats, and battlefield injuries is. Senior DoD leaders on this panel will discuss the concepts of operations, platforms for sustainment and response, and current research and development priority areas that include opioids, regenerative medicine, traumatic brain injury, chem/bio defense, and emerging infectious diseases.
Moderator: Hannah Feldman, Joint Project Management Office, Medical Countermeasure Systems
Panelists: Nicole Kilgore, Joint Product Lead, Platforms for Rapid Integrated Solutions to Medical Countermeasures (PRISM), Joint Project Manager, Medical Countermeasure Systems
Lieutenant Colonel Matthew Clark, Joint Product Manager, Chemical Defense Pharmaceuticals, Joint Project Manager, Medical Countermeasure Systems
Dr. Mark Dertzbaugh, Civilian Deputy to the Principal Assistant for Research & Technology, U.S. Army Medical Research and Materiel Command
Colonel Gary Wheeler, Commander, U.S. Army Medical Research Institute of Infectious Diseases, U.S. Army Medical Research and Materiel Command
Dr. David Hone, Chief Scientist, Vaccine and Therapeutic Division, Joint Science and Technology Office, Defense Threat Reduction Agency